Home News S'pore could have a by early 2021, pharma says

S’pore could have a Covid-19 vaccine by early 2021, pharma says

Arcturus Therapeutics, has been collaborating with Duke-NUS scientists on the vaccine, and their early-stage clinical trials shows positive results

Author

Date

Category

- Advertisement -

SINGAPORE – Singapore could possibly have a by early next year.

A report in The Straits Times explained the preliminary shipment of the vaccine, which was co-developed with Singapore researchers, is scheduled for the first quarter of 2021.

The American pharmaceutical company, Arcturus Therapeutics, has been collaborating with Duke-NUS scientists on the vaccine, and the company made an announcement on Monday (November 9) that their early-stage clinical trials has had positive results so far.

Alongside this news, the pharma company also shared that Singapore’s Economic Development Board (EDB) is releasing S$60.5 million to complete the vaccine. They also said that the EDB will be given the choice to purchase at pre-negotiated prices of up to US$175 million worth of vaccines.

- Advertisement -

Co-developer of the vaccine, Duke-NUS Medical School Professor Ooi Eng Eong, also shared that it seems a single dose could already prove effective.

Professor Eong, who also sits on the Vaccine Platform Scientific Advisory Board of Arcturus, explained that “This differentiates this investigational vaccine from many other Covid-19 vaccines in development.”

“The vaccine has the potential to provide important public health benefits by greatly facilitating broad administration across multiple populations worldwide,” he added.

According to Andy Sassine, Arcturus’ chief financial officer, the Singapore funding will boost the firm’s resources in order to maintain the rapid scale-up of the vaccine. This is also so that the pharmaceutical company can keep up their current agreements with both Israel and Singapore, as well as other possible supply deals that could occur in 2021.

This is not the only vaccine that is finding their preliminary studies to be increasingly promising. Pfizer and BioNTech have also announced that they have a 90 per cent effective vaccine in the works too.

As shared in a straitstimes.com report, Pfizer CEO and chairman Albert Bourla said, “The first set of results from our phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19.”

As for the Arcturus trials done in Singapore, around 106 volunteers enrolled in the trials with 28 subjects receiving placebos. Moreover, 78 volunteers were given one dose of the vaccine while the remaining subjects were given two injections.

Researchers have watched out for negative side effects within the patients but so far, the findings have been positive in both human immune response and safety. The pharma company also shared that no subjects have withdrawn from the trials, nor have there been any serious adverse responses in patients from the treatment thus far.

With new Covid-19 infections rising every day, and the world count reaching over 50 million infections globally, the hopes for a possible effective vaccine could not come any sooner. -/TISG

Please follow and like us:
Tweet
Share
- Advertisement -

No year-end bonus for civil servants; lower-wage staff to get one-off S$1,200

The Public Service Division (PSD) announced yesterday (27 Nov) that civil servants will not receive a year-end bonus payment and that lower-wage staff will receive a one-time payment of S$1,200, in view of the economic impact of the COVID-19 pandemic. In a...

Netizens ask why some employers demand to see PSLE results if they are not defined by scores

Responding to Education Minister Lawrence Wong's advise to 12-year-olds that they are not defined by their Primary School Leaving Examination (PSLE) results, some netizens have asked why some prospective employers demand to see job applicants' PSLE scores if what he said...

“A genius cut down by drugs” — K Shanmugam pays tribute to Diego Maradona

Singapore -- Law and Home Affairs Minister K Shanmugam paid tribute to football legend Diego Maradona, who passed away on Wednesday (Nov 25), and called him a "genius cut down by drugs" in a social media post on Thursday (Nov 26).   Maradona...
Please follow and like us:
Tweet
Share
Follow Me
Tweet